Abstract
In a recent issue of Cell, Dezfulian et al. develop a genome-scale platform to enable high-throughput identification of CD4(+) T cell epitopes. This platform enables unbiased screens to discover antigens recognized by CD4(+) T cells in cancer, infectious diseases, and autoimmunity.